Home
Get the Flash Player to see this player.

Main Menu

Home

Member Login

feed image
(Cholesterol guidelines) Red yeast rice demonstrates cholesterol-lowering potential (Nutraingredient

More info...
The herbal supplement was found to be effective in reducing the low-density lipoprotein (LDL) cholesterol level among 62 patients with hyperlipidemia and a history of discontinuation of statin therapy due to myalgias.


Cholesterol OK? Statins Still Help Heart (WebMD)

Millions of people without established heart disease could benefit from cholesterol-lowering statin therapy even if they don't have high cholesterol, a new analysis suggests.


Newly discovered gene regulates balance of 'bad' cholesterol (PhysOrg)

In an article in Science, Noam Zelcer from the LACDR (The Netherlands) describes a previously unknown mechanism for regulating the amount of LDL cholesterol. This offers opportunities for supplementing and improving the effect of so-called statins: medicines that remove 'bad' cholesterol from the bloodstream.


Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial (T-Net British Columbia)

Vancouver, BC, July 2, 2009--(T-Net)--Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP. ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being developed as a treatment for patients with elevated low-density lipoprotein (LDL) cholesterol, or "bad" cholesterol, who are not well served by current ...


Diets high in protein, cholesterol linked to liver cancer (New Kerala)

Washington, July 2 : Diets high in protein and cholesterol are linked with a higher risk of hospitalization or death due to cirrhosis or liver cancer, while diets high in carbohydrates are associated with a lower risk, according to the latest research.


Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial (Marketwire)

VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 2, 2009) - Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP. ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being developed as a treatment for patients with elevated low-density lipoprotein (LDL) cholesterol, or "bad" cholesterol, who are not well ...


Cholesterol
 
< Prev   Next >